Qiu Mantang, Feng Dongjie, Zhang Haitian, Xia Wenjia, Xu Youtao, Wang Jie, Dong Gaochao, Zhang Yewei, Yin Rong, Xu Lin
Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China.
The Fourth Clinical College of Nanjing Medical University, Nanjing, China.
Oncotarget. 2016 Mar 29;7(13):16012-22. doi: 10.18632/oncotarget.7559.
Increasing evidence has highlighted the critical roles of long non-coding RNAs (lncRNAs) as biomarkers and therapeutic targets for cancer. Here, we characterized lncRNA expression profile in lung adenocarcinoma (LUAD). A training-validation method was applied to identify differentially expressed lncRNAs between LUAD samples and normal samples. 856 differentially expressed lncRNAs were identified. Bioinformatics analyses showed that these lncRNAs were located nearby transcription start sites and key regulators of cancer and these lncRNAs were involved in many critical biological processes. We found the lung cancer associated lncRNA 6 (LCAL6) was significantly unregulated and predicted survival in LUAD. Silence of LCAL6 inhibited LUAD tumor cell growth both in vitro and in vivo. To summary, we comprehensively analyze lncRNA expression profile in LUAD and provide resources for further search for clinical biomarkers and therapeutic targets of LUAD.
越来越多的证据表明,长链非编码RNA(lncRNA)作为癌症的生物标志物和治疗靶点发挥着关键作用。在此,我们对肺腺癌(LUAD)中的lncRNA表达谱进行了特征分析。采用训练-验证方法来鉴定LUAD样本与正常样本之间差异表达的lncRNA。共鉴定出856个差异表达的lncRNA。生物信息学分析表明,这些lncRNA位于转录起始位点附近且是癌症的关键调节因子,并且这些lncRNA参与了许多关键的生物学过程。我们发现肺癌相关lncRNA 6(LCAL6)在LUAD中显著上调并可预测生存情况。沉默LCAL6在体外和体内均抑制LUAD肿瘤细胞生长。总之,我们全面分析了LUAD中的lncRNA表达谱,并为进一步寻找LUAD的临床生物标志物和治疗靶点提供了资源。